Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer

NCT01160419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Docetaxel 50 mg/m2, 1-hour-Infusion, day 1
DRUG: Oxaliplatin 85 mg/m², 2-hour-Infusion, day 1
DRUG: Folinic acid 200 mg/m², 1-2-hour-Infusion, day 1
DRUG: 5-FU 2600 mg/m², 24-hour-Infusion, day 1

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

[object Object]